Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis.
Yasna Rostam-AbadiHossein RafiemaneshJaleh GholamiBehrang ShadlooMasoumeh Amin-EsmaeiliAfarin Rahimi-MovagharPublished in: Harm reduction journal (2020)
The prevalence of HBV infection among non-injecting PWUD and even PWID was not considerably higher than the Iranian general population. This might be the result of extensive harm reduction interventions in Iran. However, it seems that there are subgroups of PWID, who do not adequately benefit from existing harm reduction interventions. Future programs should more specifically target these high-risk groups.